Filling the need for trusted information on national health issues

Data Show U.S. Trade Deals Not Spurring Increases In Drug Prices, Could Have Implications For TPP

Council on Foreign Relations: The Long Fight Over Trade and Medicines
In an online interactive, Thomas J. Bollyky, senior fellow for global health, economics, and development at CFR, examines new data suggesting U.S. trade deals are not be spurring a “discernable trend toward more expensive original or branded versions of medicines and away from cheap unbranded generic drugs, either as a matter of volume or spending. … An explanation of the potential reasons for the (as of yet) limited effects of recent U.S. trade deals on medicines and its implications for the TPP appears in Foreign Affairs…” (3/24).